ConductScience.org, home

Paper17526857

Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.

Zong J and 5 others. J Clin Pharmacol, 2007. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers. Papers, record 17526857. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17526857

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.
PubMed
Journal
J Clin Pharmacol
PubMed
Year
2007
PubMed
Publication types
Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2018-12-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zong JJian
2Chittick GEGregory E
3Wang LHLaurene H
4Hui JJames
5Begley JAJohn A
6Blum MRM Robert

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
2-AminopurineMajor topic
Anti-HIV AgentsMajor topic
DeoxycytidineMajor topic
Reverse Transcriptase InhibitorsMajor topic
StavudineMajor topic
ZidovudineMajor topic
Adolescent
Adult
Area Under Curve
Cross-Over Studies
Drug Interactions
Drug Therapy, Combination
Emtricitabine
Famciclovir
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
37830105Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy.Front Reprod Health2023https://conductscience.org/library/papers/37830105PubMed
36365101Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.Pharmaceutics2022https://conductscience.org/library/papers/36365101PubMed
35067869Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.Clin Pharmacokinet2022https://conductscience.org/library/papers/35067869PubMed
33604534Ozonation products of zidovudine and thymidine in oxidative water treatment.Water Res X2021https://conductscience.org/library/papers/33604534PubMed
31602556Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment.Drugs R D2019https://conductscience.org/library/papers/31602556PubMed
31489678Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.J Clin Pharmacol2020https://conductscience.org/library/papers/31489678PubMed
29781044Sleeve Gastrectomy in Morbidly Obese HIV Patients: Focus on Anti-retroviral Treatment Absorption After Surgery.Obes Surg2018https://conductscience.org/library/papers/29781044PubMed
26282407Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26282407PubMed
24995851Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.Br J Clin Pharmacol2014https://conductscience.org/library/papers/24995851PubMed
24492366Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24492366PubMed
22129166Effect of pregnancy on emtricitabine pharmacokinetics.HIV Med2012https://conductscience.org/library/papers/22129166PubMed
21570912Use of antineoplastic agents in patients with cancer who have HIV/AIDS.Lancet Oncol2011https://conductscience.org/library/papers/21570912PubMed
21464241Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21464241PubMed
19104016Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19104016PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17526857

GET https://conductscience.org/api/papers/v1/17526857/authors